Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year 2023 financial results, for the period ended December 31, on Thursday, March 14, 2024. Pharming will host a presentation for analysts and investors at 13:30 CET/08:30 am EDT on March 14, 2024. To participate in the conference call, please register in advance using the link below. Once registered,...